Explore Stanford Medicine
Stanford Medicine News
-
RNA molecule aids DNA damage response
Stanford researchers have found that a tumor suppressor known as p53 is stabilized by a regulatory RNA molecule called DINO. The interaction helps a cell respond to DNA damage and may play a role in cancer development and premature aging.
-
App for studying peripheral artery disease
Researchers hope people who have the condition will download the app and enroll in a study that will provide insights into patterns of the disease’s progression and may point toward new methods of treatment.
-
Prakash wins prestigious MacArthur grant
The bioengineer develops novel tools for “frugal science” — inexpensive devices that can be used to tackle global health problems and that also aim to democratize access to scientific experience.
Precision Health
Stanford Medicine is leading the biomedical revolution to improve health, defining and developing care that is proactive, predictive and precise.
Diversity
Diversity in all forms enhances Stanford Medicine's core missions — education, research and health care.
More about diversity
A Legacy of Innovation
-
First synthesis of biologically active DNA in test tube
Nobel laureate Arthur Kornberg creates a strand of biologically active DNA, paving the way for studies of genetics.
-
First adult human heart transplant in the United States
Norman Shumway successfully transplants a heart into 54-year-old steelworker Mike Kasperak, who survives for 14 days.
-
First expression of a foreign gene implanted in bacteria by recombinant DNA methods
Geneticist Stanely Cohen transfers a foreign gene into bacterial cells, which then express the gene.
-
First successful human combined heart/lung transplant in the world (fourth attempted worldwide)
Mary Gohlke receives the world's first combined heart and lung transplant in a landmark operation led by surgeon Bruce Reitz.
-
Isolation of a gene coding for part of the T-cell receptor, a key to the immune system’s function
Immunologist Mark Davis characterizes the T-cell receptor, believed to regulate the body's response to infectious agents and cancerous diseases.
-
Isolation of pure hematopoietic stem cells from mice
Pathologist Irving Weissman isolates a rare mouse cell, known as the hematopoetic stem cell, which gives rise to all the cells of the blood and immune systems.
-
First use of gene expression profiling to predict cancer outcomes
-
Application and expansion of optogenetics, a technique to control brain cell activity with light
Bioengineer Karl Deisseroth and his team develop a technique known as optogenetics that allows them to genetically alter brain cell activity in mice with light.